Elekta AB (EKTAY)
8.024
+0.15
(+1.96%)
USD |
OTCM |
May 22, 16:00
Elekta 1 Year Total Returns (Daily): 0.03% for May 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 22, 2024 | 0.03% |
| May 21, 2024 | -3.11% |
| May 20, 2024 | -4.59% |
| May 17, 2024 | -6.55% |
| May 16, 2024 | -7.07% |
| May 15, 2024 | -7.57% |
| May 14, 2024 | -7.26% |
| May 13, 2024 | -7.82% |
| May 10, 2024 | -10.77% |
| May 09, 2024 | -12.70% |
| May 08, 2024 | -13.52% |
| May 07, 2024 | -13.12% |
| May 06, 2024 | -12.94% |
| May 03, 2024 | -13.63% |
| May 02, 2024 | -12.74% |
| May 01, 2024 | -12.89% |
| April 30, 2024 | -10.92% |
| April 29, 2024 | -11.48% |
| April 26, 2024 | -14.44% |
| April 25, 2024 | -16.97% |
| April 24, 2024 | -14.66% |
| April 23, 2024 | -10.04% |
| April 22, 2024 | -11.51% |
| April 19, 2024 | -10.48% |
| April 18, 2024 | -10.80% |
| Date | Value |
|---|---|
| April 17, 2024 | -6.63% |
| April 16, 2024 | -11.28% |
| April 15, 2024 | -9.76% |
| April 12, 2024 | -10.81% |
| April 11, 2024 | -5.85% |
| April 10, 2024 | -3.06% |
| April 09, 2024 | -1.58% |
| April 08, 2024 | 1.00% |
| April 05, 2024 | 0.60% |
| April 04, 2024 | 1.33% |
| April 03, 2024 | 5.59% |
| April 02, 2024 | 4.31% |
| April 01, 2024 | 3.14% |
| March 28, 2024 | 3.71% |
| March 27, 2024 | 5.24% |
| March 26, 2024 | 5.24% |
| March 25, 2024 | 5.34% |
| March 22, 2024 | 1.73% |
| March 21, 2024 | 2.01% |
| March 20, 2024 | 4.13% |
| March 19, 2024 | 4.89% |
| March 18, 2024 | 4.20% |
| March 15, 2024 | 4.74% |
| March 14, 2024 | -0.55% |
| March 13, 2024 | 2.18% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-57.84%
Minimum
Sep 23 2022
107.2%
Maximum
Mar 23 2021
-2.61%
Average
-1.44%
Median
May 28 2020
1 Year Total Returns (Daily) Benchmarks
| Abliva AB | -- |
| Karolinska Development AB | 0.00% |
| Calliditas Therapeutics AB | 17.80% |
| Oncopeptides AB | -68.82% |
| Olink Holding AB | 15.58% |